G protein-coupled receptor 151 regulates glucose metabolism and hepatic gluconeogenesis
E. Bielczyk-Maczynska, M. Zhao, P.-J. H. Zushin, T. M. Schnurr, H.-J. Kim, J. Li, P. Nallagatla, P. Sangwung, C. Park, C. Cornn, A. Stahl, K. J. Svensson, J. W. Knowles
Abstract
Human genetics has been instrumental in identification of genetic variants linked to type 2 diabetes (T2D). Recently a rare, putative loss-of-function mutation in the orphan G-protein coupled receptor 151 (GPR151) was found to be associated with lower odds ratio for T2D, but the mechanism behind this association has remained elusive. Here for the first time we show that Gpr151 is a fasting- and glucagon-responsive hepatic gene which regulates hepatic gluconeogenesis. Gpr151 ablation in mice leads to suppression of hepatic gluconeogenesis genes and reduced hepatic glucose production in response to pyruvate. Importantly, the restoration of hepatic Gpr151 levels in the Gpr151 knockout mice reverses the reduced hepatic glucose production. Our findings establish a previously unknown role of Gpr151 in the liver and provides an explanation to the lowered T2D risk in individuals with nonsynonymous mutations in GPR151. This study highlights the therapeutic potential of targeting GPR151 for treatment of metabolic disease.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HNF4α-TET2-FBP1 axis contributes to gluconeogenesis and type 2 diabetes
Hongchen Li, Xinchao Zhang, … Yanping Xu·bioRxiv·Sep 29, 2024
- GDF15 is a Critical Renostat in the Defense Against Hypoglycemia
Z. Li, X. Zhang, … R. J. Perry·bioRxiv·Jun 22, 2023
- Reducing the CAV1-dependent trafficking of G6PC1 in the liver protects against the development of type 2 diabetes
Lorine Da Costa, Cécile Saint-Béat, … Amandine Gautier‐Stein·bioRxiv·Apr 26, 2025
- Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids
M. R. Martino, M. Gutierrez-Aguilar, … B. N. Finck·Cell ReportsPeer-reviewed·Apr 1, 2022
- G-PROTEIN COUPLED RECEPTOR 19 (GPR19) KNOCKOUT MICE DISPLAY SEX-DEPENDENT METABOLIC DYSFUNCTION
B. A. S. Mushala, B. Xie, … I. Scott·bioRxiv·Oct 29, 2022
- Discovery of Novel and Selective GPR17 Antagonists as Pharmacological Tools for Developing New Therapeutic Strategies in Diabetes and Obesity
Hu Zhu, Jason Michael Conley, … Samarjit Patnaik·European Journal of Medicinal ChemistryPeer-reviewed·May 22, 2025